Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

GnRH agonists are used in the treatment of precocious puberty in order to improve adult height.However,the psychosocial impact of precocious puberty is often used by the clinician at diagnosis to justify treatment, but can not yet be properly assessed. It can not be considered as a rational neither for the indication to treatment, nor to assess its potential efficacy.

The overall objective of this work is to improve the conditions leading to the therapeutic decision and the procedures for monitoring girls with idiopathic central precocious puberty.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty

NCT02790112

Puberty, Precocious Adiposity

UNKNOWN NA

Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children

NCT00438217

Central Precocious Puberty

UNKNOWN PHASE4

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

NCT01073605

Growth Disorders Intrauterine Growth Retardation

COMPLETED PHASE3

Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle

NCT00004335

Hypogonadism Precocious Puberty

COMPLETED

Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size

NCT05195437

Growth Hormone Treatment

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During the day hospital, the diagnostic workup for precocious puberty will be performed and include:

* A clinical examination with pubertal stage assessment.
* A GnRH test
* A Pelvic ultrasound
* An MRI will be performed later after the results of GnRH test confirming precocious central puberty.

These reviews are conducted as part of usual care and are required to validate the inclusion criteria of patients.

The CBCL questionnaire will be completed by patient's parents and the first semi-structured interview will be conducted by a sociologist assisted by the psychologist, dedicated to the study.

Patient's follow-up will be planned 6 months after inclusion, including similar investigations (except MRI).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Puberty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6 to 8 years old girls, with idiopathic central precocious puberty defined as:

* Onset of clinical signs between 6 and 8 years excluded: breast development (Tanner stage S2 or more), possibly with pubic hair or accelerated growth rate.
* The GnRH test: LH peak\> 5 IU / l during the test.
* Pelvic ultrasound: uterine length\> 34 mm
* The normality of the hypothalamic-pituitary region assessed by magnetic resonance imaging (MRI).
* Parental Informed and written consent